Compare CHRS & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHRS | CLAR |
|---|---|---|
| Founded | 2010 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.0M | 129.8M |
| IPO Year | 2014 | N/A |
| Metric | CHRS | CLAR |
|---|---|---|
| Price | $1.62 | $3.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | $4.02 | ★ $5.33 |
| AVG Volume (30 Days) | ★ 1.2M | 115.5K |
| Earning Date | 03-09-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 2.84% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $277,728,000.00 | $256,432,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $67.31 | $3.85 |
| P/E Ratio | $1.23 | ★ N/A |
| Revenue Growth | ★ 152.07 | N/A |
| 52 Week Low | $0.71 | $3.02 |
| 52 Week High | $1.89 | $5.08 |
| Indicator | CHRS | CLAR |
|---|---|---|
| Relative Strength Index (RSI) | 60.19 | 58.81 |
| Support Level | $1.51 | $3.50 |
| Resistance Level | $1.72 | $3.86 |
| Average True Range (ATR) | 0.13 | 0.13 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 70.47 | 72.97 |
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.